chr11-112118869-T-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000532699.1(ENSG00000255292):​n.314+29858T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.634 in 152,024 control chromosomes in the GnomAD database, including 34,172 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.63 ( 34172 hom., cov: 31)

Consequence

ENSG00000255292
ENST00000532699.1 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.317

Publications

9 publications found
Variant links:
Genes affected
SDHD (HGNC:10683): (succinate dehydrogenase complex subunit D) This gene encodes a member of complex II of the respiratory chain, which is responsible for the oxidation of succinate. The encoded protein is one of two integral membrane proteins anchoring the complex to the matrix side of the mitochondrial inner membrane. Mutations in this gene are associated with the formation of tumors, including hereditary paraganglioma. Transmission of disease occurs almost exclusively through the paternal allele, suggesting that this locus may be maternally imprinted. There are pseudogenes for this gene on chromosomes 1, 2, 3, 7, and 18. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2013]
SDHD Gene-Disease associations (from GenCC):
  • hereditary pheochromocytoma-paraganglioma
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • pheochromocytoma
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • pheochromocytoma/paraganglioma syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
  • Carney-Stratakis syndrome
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet
  • mitochondrial complex II deficiency, nuclear type 1
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • renal cell carcinoma
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • mitochondrial complex 2 deficiency, nuclear type 3
    Inheritance: AR Classification: MODERATE Submitted by: Ambry Genetics
  • mitochondrial complex II deficiency
    Inheritance: AR Classification: MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet
  • Cowden disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • intestinal cancer
    Inheritance: AD Classification: LIMITED Submitted by: G2P
  • mitochondrial disease
    Inheritance: AR Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.789 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ENSG00000255292ENST00000532699.1 linkn.314+29858T>C intron_variant Intron 3 of 5 3 ENSP00000456434.1 H3BRW5

Frequencies

GnomAD3 genomes
AF:
0.635
AC:
96413
AN:
151906
Hom.:
34183
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.299
Gnomad AMI
AF:
0.834
Gnomad AMR
AF:
0.656
Gnomad ASJ
AF:
0.727
Gnomad EAS
AF:
0.582
Gnomad SAS
AF:
0.742
Gnomad FIN
AF:
0.811
Gnomad MID
AF:
0.699
Gnomad NFE
AF:
0.795
Gnomad OTH
AF:
0.655
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.634
AC:
96417
AN:
152024
Hom.:
34172
Cov.:
31
AF XY:
0.637
AC XY:
47358
AN XY:
74296
show subpopulations
African (AFR)
AF:
0.298
AC:
12366
AN:
41442
American (AMR)
AF:
0.656
AC:
9999
AN:
15246
Ashkenazi Jewish (ASJ)
AF:
0.727
AC:
2521
AN:
3470
East Asian (EAS)
AF:
0.582
AC:
3002
AN:
5160
South Asian (SAS)
AF:
0.743
AC:
3584
AN:
4822
European-Finnish (FIN)
AF:
0.811
AC:
8579
AN:
10576
Middle Eastern (MID)
AF:
0.684
AC:
201
AN:
294
European-Non Finnish (NFE)
AF:
0.795
AC:
54036
AN:
67992
Other (OTH)
AF:
0.648
AC:
1368
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1457
2914
4371
5828
7285
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
764
1528
2292
3056
3820
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.738
Hom.:
146039
Bravo
AF:
0.607
Asia WGS
AF:
0.626
AC:
2181
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
1.2
DANN
Benign
0.59
PhyloP100
-0.32

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs360726; hg19: chr11-111989592; COSMIC: COSV73256785; API